In contrast, growing evidence indicates that the unfavorable prognosis of IDH-wildtype (wt) WHO grade II and III astrocytoma reflects the presence of previously unrecognized glioblastoma [6, 7]. This evidence concerns the gene IDH2 and astrocytoma (excluding glioblastoma).